Promino Nutritional Sciences Inc. (CSE:MUSL)
Canada · Delayed Price · Currency is CAD 0.0300
+0.0050 (20.00%)
At close: Aug 28, 2026
CSE:MUSL Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.7 | 2.15 | 0.26 | 0.48 | 4 | 2.36 | |
Revenue Growth | 69.21% | 726.31% | -45.50% | -88.05% | 69.80% | 140.65% |
Cost of Revenue | 1.59 | 1.7 | 0.6 | 1.87 | 5.08 | 2.18 |
Gross Profit | 0.11 | 0.45 | -0.34 | -1.39 | -1.08 | 0.17 |
Selling, General & Admin | 2.73 | 3.05 | 3.96 | 3.65 | 9.25 | 10.29 |
Research & Development | 0.02 | 0.02 | 0.11 | 0.01 | 0.02 | 0.02 |
Operating Expenses | 3.05 | 3.45 | 6.29 | 4.32 | 9.3 | 10.39 |
Operating Income | -2.93 | -3 | -6.63 | -5.71 | -10.38 | -10.21 |
Interest Expense | -0.29 | -0.31 | -0.58 | -0.51 | -0.13 | -0.03 |
Currency Exchange Gain (Loss) | 0.5 | -0.32 | 0.4 | -0.09 | 0.2 | 0.08 |
Other Non Operating Income (Expenses) | -0.72 | -0.02 | -0.01 | -0.13 | -0.03 | 1.23 |
EBT Excluding Unusual Items | -3.44 | -3.64 | -6.82 | -6.43 | -10.35 | -8.93 |
Gain (Loss) on Sale of Investments | -0.05 | -0.12 | -0.29 | - | - | - |
Gain (Loss) on Sale of Assets | 0.56 | 0.56 | - | - | - | - |
Asset Writedown | - | - | -0.03 | -0.04 | - | - |
Legal Settlements | - | - | -0.44 | - | - | - |
Other Unusual Items | 0.5 | 0.21 | 0.51 | 0.66 | - | 0.15 |
Pretax Income | -2.44 | -2.99 | -7.07 | -5.81 | -10.35 | -8.78 |
Net Income | -2.44 | -2.99 | -7.07 | -5.81 | -10.35 | -8.78 |
Net Income to Common | -2.44 | -2.99 | -7.07 | -5.81 | -10.35 | -8.78 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 158 | 132 | 83 | 38 | 37 | 28 |
Shares Outstanding (Diluted) | 158 | 132 | 83 | 38 | 37 | 28 |
Shares Change | 34.47% | 58.61% | 116.65% | 2.30% | 34.49% | 289.50% |
EPS (Basic) | -0.02 | -0.02 | -0.09 | -0.15 | -0.28 | -0.31 |
EPS (Diluted) | -0.02 | -0.02 | -0.09 | -0.15 | -0.28 | -0.31 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.13 | -1.28 | -5.63 | -1.79 | -4.53 | -9.98 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.07 | -0.05 | -0.12 | -0.36 |
Gross Margin | 6.64% | 20.86% | -131.74% | -291.49% | -27.05% | 7.42% |
Operating Margin | -172.58% | -139.31% | -2545.61% | -1194.30% | -259.45% | -433.35% |
Profit Margin | -143.74% | -139.06% | -2713.35% | -1214.54% | -258.56% | -372.52% |
Free Cash Flow Margin | -125.30% | -59.44% | -2160.89% | -375.12% | -113.18% | -423.43% |
EBITDA | - | - | -6.61 | -5.69 | -10.35 | -10.18 |
EBITDA Margin | - | - | - | - | -258.68% | - |
D&A For EBITDA | - | - | 0.02 | 0.02 | 0.03 | 0.03 |
EBIT | -2.93 | -3 | -6.63 | -5.71 | -10.38 | -10.21 |
EBIT Margin | -172.58% | -139.31% | - | - | -259.45% | - |
Advertising Expenses | - | 1.23 | 0.66 | 0.76 | 2.61 | 3.67 |